Article info
Hepatology
Original article
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- Correspondence to Professor Chun-Ying Wu, Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, 155, Sec. 2, Linong Street, Taipei 112, Taiwan; chun{at}vghtc.gov.tw
Citation
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Publication history
- Revised May 16, 2012
- Accepted May 18, 2012
- First published July 7, 2012.
Online issue publication
February 28, 2013
Article Versions
- Previous version (7 July 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions